D. Md. -- U.S. District Court for the District of Maryland
Significant Victory for Porter Hayden in Asbestos Coverage Dispute over Exhaustion of Insurers’ Excess Policies
Case | Insurance Coverage | January 2, 2014Porter Hayden prevailed on a significant coverage dispute when the U.S. District Court for the District of Maryland confirmed that Maryland’s “horizontal exhaustion” rule requires only exhaustion of the primary policies in a particular year on…
Porter Hayden wins ruling that insurance coverage is an asset surviving bankruptcy and defeats insurer’s motion to indemnify Porter Hayden only for actual, discounted payments of its bankruptcy-settlement trust.
Case | Insurance Coverage | March 6, 2012On March 6, 2012, the United States District Court for the District of Maryland ruled in favor of arguments made by Hollingsworth LLP, that insurance coverage is an asset surviving bankruptcy and that Porter Hayden Company…
In Major Precedent for Drugmakers, Federal Court Precludes Punitives Under New Jersey Law
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | September 5, 2012Zimmerman v. Novartis Pharm. Corp., No. 8:08-cv-02089-RWT (D. Md. Sept, 5, 2012)
Novartis Rebuts Plaintiff’s Changing Failure-to-Warn Theories, Obtaining Summary Judgment on Eve of Trial
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | November 16, 2012Judge Roger Titus of the U.S. District Court for the District of Maryland granted summary judgment in favor of Novartis Pharmaceuticals Corporation in a case alleging that plaintiff’s treatment with Novartis’s drugs Aredia and Zometa caused osteonecrosis…